Funding for Ebola hides decline in funding

Funding for Ebola hides decline in funding

Public funding for neglected disease research and development was actually at its lowest level in seven years, with public funding for non-Ebola R&D dropping by $62m in 2014. As the world’s biggest funder of neglected disease R&D, much of this decline has been driven by the US Government. US Government funding for non-Ebola neglected disease R&D fell again in 2014 – further extending the large sequester-related cuts of the previous year – to be nearly a quarter of a billion dollars ($221m) below its 2009 peak.